FTC Furthers Probe Into Mylan's Keppra Settlement
The U.S. Federal Trade Commission has served Mylan Inc. with a civil investigative demand related to the drugmaker's settlement of a patent infringement suit over its generic version of epilepsy treatment...To view the full article, register now.
Already a subscriber? Click here to view full article